Helpline 07939 046 030
Freephone 0300 102 17 22*

Living with Neurofibromatosis Type 1: An Anthropological Study

02 October 2020

Naomi Marshall is a PhD student at the University of Oxford, and she’s looking to talk to people in the UK who can help answer these questions.

Naomi’s an anthropologist, which means she studies cultures by hearing about them first-hand, in people’s own words. Growing up in both America and Britain, Naomi learned how important culture is for shaping people’s everyday lives, especially when it comes to health. Her field, medical anthropology, explores how people’s backgrounds influence how they experience health conditions. Getting to know people in-depth, whether in a single interview, or even over the course of several months, is what makes anthropology different to other kinds of research. The more you can talk about your everyday life (including your values, opinions, experiences, and aspirations), the better Naomi’s research will be.

This research is important because gathering and sharing NF1 stories from diverse perspective can help patients and doctors alike. Having accessible accounts from around the world of how people live and thrive with NF1 can inform and inspire people living with the condition. Data from this research can also help train healthcare providers to become more culturally sensitive. Moreover, having detailed accounts of the variety of NF1 experiences can inform policymakers, such as legislators and bioethicists. So while taking part in this research is unpaid, it is still an exciting and rewarding opportunity to share your story. You can be from any background to take part! You just have to be over 16, live in the UK, and be willing to chat about your experiences with NF1.

What does taking part in this research involve?

Naomi is conducting casual, one-on-one interviews over Zoom. Interviews start with some prepared questions, followed by friendly, unstructured conversations – giving you the freedom to share your story in whatever way you feel is best. No identifying information (such as your name) will be shared in research outputs.

Interviews take about 1 hour. Questions will cover your NF1 symptoms and diagnosis, your sociocultural background, your experience of lockdown during COVID-19, any support you may receive from friends or family, and your experiences at work, school, or home.

One-off interviews are great and can help this project cover a variety of perspectives. But, if you have the time, it would also be great to consider taking part in multiple interviews with Naomi. Of course, there is no pressure to take part in multiple interviews! You can decide after your first interview if you’d like to take part in more. Participants are also free to withdraw from the research at any time without giving reason.

We in the head office at Nerve Tumours UK are supporting Naomi all the way throughout her research. The head office will take part in the interviewing process as well as some of our NF specialist nurses and medics to map out and understand how the situation for those affected with Neurofibromatosis is organised and hopefully will learn and apply findings to our service improvement.

I want to take part/I want to learn more!

Great! To schedule an interview at your convenience, follow the link below.

Please include times and dates when you might be available. You can schedule an interview for any time, including weekends and evenings.

If you have any questions, you can e-mail Naomi directly at naomi.marshall@anthro.ox.ac.uk 

Ethics approval code: SAME_C1A_20_008 University of Oxford

 

Nerve Tumours UK is not responsible for any data collection or content of the project. 

Filter News

Filter by Date
Category
Reset

Oxford’s John Radcliffe Hospital celebrate NF2 Awareness Day

We set out to promote and educate people about NF2 & the service offered in Oxford & Southwest Region for patients

Read More

Care Quality Commission survey

Take part - if you are from an ethnic minority, have a long term physical condition & live in selected SW London boroughs

Read More

CAR research family planning decision making

This CAR UWE research explores family planning & decision making for people with a visible difference which can be inherited

Read More

Shine A Light 2024

The Shine A Light 2024 campaign had 133 buildings around the UK & the Republic of Ireland lit up in blue!

Read More

Guidance on sudden hearing loss in NF2-related Schwannomatosis (NF2-SWN)

Symptoms, diagnosis & treatment of sudden hearing loss, from Juliette Buttimore, Nurse Practitioner NF2 Service Addenbrooke's

Read More

NF2 Day 2024 by Emily Owen

A reflective poem for World NF2 Day, to celebrate people living with NF2

Read More

Connor’s NF2 story

Connor's mum Tracy's maternal instincts proved invaluable when fighting to get Connor's symptoms investigated

Read More

Jo’s Shine A Light Family Fun Day

The family fundraiser was supported by Dr Shruti Garg, member of the Nerve Tumours UK Medical Advisory Board

Read More

Erin’s 24 hour charity live stream

Erin has NF1 and is raising awareness with a 24 hour live charity stream to Shine A Light on NF

Read More

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK